IL-1RL1 (also known as IL-33R or ST2), involved in initiating inflammatory responses through IL-33 binding, is associated with IBD risk through gene polymorphisms in IL-33 and IL1RL1 (66, 67). The gene discussed is IL33; the disease is inflammatory bowel disease.